Cardiomyopathy Market Growth, Analysis Report, Share, Trends and Overview 2022-2028
The global
cardiomyopathy market is anticipated to grow at a considerable CAGR of 4.2%
during the forecast period (2022-2028). The key companies operating in the
industry are highly inclined towards the adoption of different growth
strategies including capacity expansion, partnerships, mergers and
acquisitions, geographical expansion, new product launches, and product
innovation to remain competitive in the marketplace this is anticipated to hold
significant growth. For instance, In April 2022, LianBio’s and Bristol-Myers
Squibb partnered and developed Camzyos medicine which has been approved by U.S.
Food and Drug Administration (FDA). This is developed for the treatment class
II-III obstructive hypertrophic cardiomyopathy for cardiac myosin that targets
the underlying pathophysiology of obstructive HCM. Similarly, in November 2021,
Sanofi has partnered with MyoKardia, both in partnership will develop and
discover targeted therapeutics to treat patients with genetic heart disease.
The partnership is mainly for three programs, in that two are focused on
hypertrophic cardiomyopathy (HCM), while the other one is on dilated
cardiomyopathy (DCM).
A full report of Cardiomyopathy Market is available
at: https://www.omrglobal.com/industry-reports/cardiomyopathy-market
Furthermore,
in May 2020, BioMarin Pharmaceutical Inc. and DiNAQOR AG collaborated to develop gene therapy to treat
rare genetic cardiomyopathies. The new partnership is under DiNAQOR’s lead
program in which DiNA-001 for MYBPC3 hypertrophic cardiomyopathy is being
licensed. This is developing focused on the treatment of MYBPC3-linked
cardiomyopathy. Whereas, in September 2019, Abbott has received FDA approval
for its troponin blood test, which identifies heart attacks hours earlier than
previous methods being used. Moreover, it has also launched a training
partnership program to help the US hospital staff incorporate the automated
blood test into their ER workflows and guide them about new tests developed.
To learn more about this report request a sample
copy @ https://www.omrglobal.com/request-sample/cardiomyopathy-market
Market Coverage
• The market number available for –
2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Product
o By Technology
o By Application
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
·
Competitive
Landscape- Becton and Dickson & Co., Boston Scientific Corp., Mylan N.V,
Pfizer, Inc., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries
Ltd., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate
the market in the base year?
• Which segment and region will
project the fastest growth in the market?
• How has COVID-19 impacted the
market?
o Deviation from the pre-COVID-19
forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing
challenges to sustain growth?
• Where is the investment
opportunity?
Global Cardiomyopathy Market Report Segment
By Type
·
Dilated Cardiomyopathy
·
Restrictive
Cardiomyopathy
·
Unclassified
Cardiomyopathy
·
Hypertrophic
Cardiomyopathy
·
Arrhythmogenic
Right Ventricular Dysplasia s
By Diagnosis Test
·
Blood Tests
·
Cardiac MRI
·
Chest X-Ray
·
Cardiac CT Scan
·
Echocardiogram
·
Treadmill Stress
Test
·
Electrocardiogram
(Ecg)
·
Cardiac
Catheterization
·
Genetic Testing or
Screening
By Treatment
• Medication
• Nonsurgical Procedures
o Septal Ablation
o Radiofrequency Ablation
• Surgery
o Septal Myectomy
o Heart Transplant
By End-User
·
Homecare
·
Hospitals And
Clinics
·
Diagnostic Center
·
Other
Cardiomyopathy Market– Segment by Region
North America
·
United States
·
Canada
Europe
·
Germany
·
United Kingdom
·
France
·
Spain
·
Italy
·
Rest of Europe
Asia-Pacific
·
China
·
Japan
·
India
·
Rest of
Asia-Pacific
Rest of the World
·
Middle East &
Africa
·
Latin America
Company Profiles
·
Abbott
·
AstraZeneca
·
Becton, Dickinson
and Co.
·
BIOMÉRIEUX, INC.
·
Bio-Rad
Laboratories, Inc
·
Boston Scientific
Corp.
·
Bristol-Myers
Squibb Co.
·
F. Hoffmann-La
Roche Ltd
·
Ionis
Pharmaceuticals
·
Janssen Pharmaceuticals,
Inc.
·
Laboratory Corp.
·
Medtronic Plc.
·
Merck & Co.,
Inc.
·
Mylan N.V.
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more
than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and
after purchasing your report.
About Orion Market Research
Orion
Market Research (OMR) is a market research and consulting company known for its
crisp and concise reports. The company is equipped with an experienced team of
analysts and consultants. OMR offers quality syndicated research reports,
customized research reports, consulting and other research-based services.
Media Contact:
Contact
Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no:
+91 780-304-0404
Company
Name: Orion Market Research
0 Comments